120 related articles for article (PubMed ID: 17505062)
1. Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity.
Ma Y; Hu C; Riegel AT; Fan S; Rosen EM
Mol Endocrinol; 2007 Aug; 21(8):1905-23. PubMed ID: 17505062
[TBL] [Abstract][Full Text] [Related]
2. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
Hua KT; Way TD; Lin JK
Mol Carcinog; 2006 Aug; 45(8):551-60. PubMed ID: 16637063
[TBL] [Abstract][Full Text] [Related]
3. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor (ER)alpha and ER beta are both expressed in human ejaculated spermatozoa: evidence of their direct interaction with phosphatidylinositol-3-OH kinase/Akt pathway.
Aquila S; Sisci D; Gentile M; Middea E; Catalano S; Carpino A; Rago V; Andò S
J Clin Endocrinol Metab; 2004 Mar; 89(3):1443-51. PubMed ID: 15001646
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.
Ma Y; Fan S; Hu C; Meng Q; Fuqua SA; Pestell RG; Tomita YA; Rosen EM
Mol Endocrinol; 2010 Jan; 24(1):76-90. PubMed ID: 19887647
[TBL] [Abstract][Full Text] [Related]
6. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Oncogene; 2001 Jan; 20(1):77-87. PubMed ID: 11244506
[TBL] [Abstract][Full Text] [Related]
7. Akt activation by estrogen in estrogen receptor-negative breast cancer cells.
Tsai EM; Wang SC; Lee JN; Hung MC
Cancer Res; 2001 Dec; 61(23):8390-2. PubMed ID: 11731414
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
10. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I.
Martin MB; Franke TF; Stoica GE; Chambon P; Katzenellenbogen BS; Stoica BA; McLemore MS; Olivo SE; Stoica A
Endocrinology; 2000 Dec; 141(12):4503-11. PubMed ID: 11108261
[TBL] [Abstract][Full Text] [Related]
11. p300 Modulates the BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Cancer Res; 2002 Jan; 62(1):141-51. PubMed ID: 11782371
[TBL] [Abstract][Full Text] [Related]
12. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
13. An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.
Acconcia F; Manavathi B; Mascarenhas J; Talukder AH; Mills G; Kumar R
Cancer Res; 2006 Nov; 66(22):11030-8. PubMed ID: 17108142
[TBL] [Abstract][Full Text] [Related]
14. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Wellstein A; Morgan E; Czubayko F; List HJ; Reiter R; Martin MB; Stoica A
Oncogene; 2003 Apr; 22(14):2073-87. PubMed ID: 12687010
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants of the BRCA1 : estrogen receptor interaction.
Ma YX; Tomita Y; Fan S; Wu K; Tong Y; Zhao Z; Song LN; Goldberg ID; Rosen EM
Oncogene; 2005 Mar; 24(11):1831-46. PubMed ID: 15674350
[TBL] [Abstract][Full Text] [Related]
16. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
17. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity.
Toulany M; Baumann M; Rodemann HP
Mol Cancer Res; 2007 Aug; 5(8):863-72. PubMed ID: 17699110
[TBL] [Abstract][Full Text] [Related]
18. Eph receptor B4 is a regulator of estrogen receptor alpha in breast cancer cells.
Schmitt F; Nguyen PH; Gupta N; Mayer D
J Recept Signal Transduct Res; 2013 Aug; 33(4):244-8. PubMed ID: 23725356
[TBL] [Abstract][Full Text] [Related]
19. PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer.
Riggio M; Polo ML; Blaustein M; Colman-Lerner A; Lüthy I; Lanari C; Novaro V
Carcinogenesis; 2012 Mar; 33(3):509-18. PubMed ID: 22180571
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells.
Mendez P; Garcia-Segura LM
Endocrinology; 2006 Jun; 147(6):3027-39. PubMed ID: 16497810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]